Pluto Biosciences, Inc

GSE150586: Next generation sequencing identifies differentially expressed genes between breast cancer with diabetes and breast cancer without diabetes

Bulk RNA sequencing

We report the application of RNA-sequencing for high-throughput profiling of transcriptomes in tumor tissues from patients with breast cancer and diabetes, and in tumor tissues from breast cancer patients without diabetes. SOURCE: Rihong Zhai (rzhai@szu.edu.cn) - Shenzhen University School of Medicine

View this experiment on Pluto Biosciences, Inc